Schedule 13D ownership disclosure

COCRYSTAL PHARMA INC

Security class unavailable · CUSIP: 19188J409

Event date: 2023-04-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-23-012282
Form type
SC 13D/A
Filer
Cocrystal Pharma, Inc.
CIK
CIK 1412486
Filed
Apr 14, 2023
Reporting period
Apr 04, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub